P-3622

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameP-3622
Drug Alias Namesqualene synthetase inhibitors (Pfizer)P-3622
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene synthase inhibitors
TargetsSqualene synthase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A